Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...

Modular Medical (Nasdaq:MODD) announced that it entered into definitive subscription agreements worth proceeds of approximately $12 million.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Biomedical engineer Joshua Doloff uses federal funding to pioneer immunotherapies that could free diabetes patients from ...

QUEBEC CITY, March 18, 2025 (GLOBE NEWSWIRE) -- Breakthrough T1D Canada is calling on the Quebec government to adopt the 2022 INESSS recommendation to eliminate current age restrictions on public ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...